Literature DB >> 18661347

Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer.

Suniti Misra1, Vincent C Hascall, Franklin G Berger, Roger R Markwald, Shibnath Ghatak.   

Abstract

Carcinomas arising from colon epithelia develop or progress in a stromal microenvironment that is elevated in hyaluronan; interactions between elevated hyaluronan and the CD44 receptors on epithelial tumor cells activate an HA-receptor tyrosine kinase-mediated cell survival pathway. In this review we provide evidence that the hyaluronan-ErbB2-PI3kinase/AKT-ss-catenin-COX-2 signaling axis leads to intestinal epithelial and colon tumor cell division and proliferation. This review includes a summary of the authors work over the past years as well as citations of specific reviews related to role of hyaluronan in the pathogenesis of colon cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18661347     DOI: 10.1080/03008200802143356

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  26 in total

1.  V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling.

Authors:  Daniel Hernández; Laia Miquel-Serra; María-José Docampo; Anna Marco-Ramell; Jennifer Cabrera; Angels Fabra; Anna Bassols
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

Review 2.  Cancer stem cell detection and isolation.

Authors:  Meysam Moghbeli; Faezeh Moghbeli; Mohammad Mahdi Forghanifard; Mohammad Reza Abbaszadegan
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

3.  Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.

Authors:  Shibnath Ghatak; Vincent C Hascall; Roger R Markwald; Suniti Misra
Journal:  J Biol Chem       Date:  2010-03-03       Impact factor: 5.157

4.  REDOX regulation of IL-13 signaling in intestinal epithelial cells: usage of alternate pathways mediates distinct gene expression patterns.

Authors:  Debasmita Mandal; Pingfu Fu; Alan D Levine
Journal:  Cell Signal       Date:  2010-06-04       Impact factor: 4.315

5.  Overexpression of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads to increased hyaluronan synthesis and cell proliferation by up-regulation of cyclin D1 in AKT-dependent pathway.

Authors:  Rachna Kaul; Paramita Saha; Mallampati Saradhi; Ramachandra L A Prasad; Soumya Chatterjee; Ilora Ghosh; Rakesh K Tyagi; Kasturi Datta
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

6.  Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung disease.

Authors:  Shibnath Ghatak; Galina S Bogatkevich; Ilia Atnelishvili; Tanjina Akter; Carol Feghali-Bostwick; Stanley Hoffman; Victor M Fresco; John C Fuchs; Richard P Visconti; Roger R Markwald; Subhas B Padhye; Richard M Silver; Vincent C Hascall; Suniti Misra
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

7.  Differential Expression of Key Signaling Proteins in MCF10 Cell Lines, a Human Breast Cancer Progression Model.

Authors:  Jae Young So; Hong Jin Lee; Pavel Kramata; Audrey Minden; Nanjoo Suh
Journal:  Mol Cell Pharmacol       Date:  2012-01-01

8.  Epithelial Ovarian Cancer and Cancer Stem Cells.

Authors:  Amr A Soliman; Alaa A Elzarkaa; Eduard Malik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis.

Authors:  Shibnath Ghatak; Suniti Misra; Russell A Norris; Ricardo A Moreno-Rodriguez; Stanley Hoffman; Robert A Levine; Vincent C Hascall; Roger R Markwald
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

10.  Novel findings about management of gastric cancer: a summary from 10th IGCC.

Authors:  Danila Penon; Letizia Cito; Antonio Giordano
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.